GUFICBIO.NS
Gufic Biosciences Limited—
—
Revenue · FY
$9.44B
Net income
$642.15M
FY 2026
EPS · diluted
$6.40
EBITDA
$1.51B
Explain this page
Arphra AIPlain-English read on Gufic Biosciences Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for GUFICBIO.NS.
Sector & industry today
LiveSectors
- Technology+1.59%
- Industrials+1.50%
- Energy+1.40%
- Basic Materials+1.36%
- Utilities+0.94%
- Consumer Cyclical+0.45%
- Real Estate+0.37%
- Consumer Defensive+0.28%
- Financial Services+0.05%
- Healthcare-0.26%
- Communication Services-0.39%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-1.54%
- Hardware, Equipment & Parts+5.17%
- Computer Hardware-4.64%
- REIT - Office+4.28%
- Communication Equipment+4.02%
- Electronic Gaming & Multimedia-3.94%
- Real Estate - Services+3.82%
- Agricultural - Machinery+3.64%
- Auto - Parts+3.58%
- Oil & Gas Energy+3.45%
- Information Technology Services+3.19%
- Copper+3.00%
Fair value
Football field →Weighted blend
$139.10
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Total assets
$13.42B
Total debt
$4.05B
Cash & equiv
$762.17M
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for GUFICBIO.NS.
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $9.44B | $1.21B | $642.15M | $6.40 | +6.80% |